Demandez un entretien de conseil sur les cellules souches
En savoir plus
Contactez-nous dès aujourd'hui !
Vous souhaitez en savoir plus sur nos services ? Remplissez le formulaire ci-dessous et nous vous contacterons dans les plus brefs délais afin de vous fournir toutes les informations nécessaires et de répondre à vos questions.
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Nr.
Source
Type de source
Diagnostic
Domaine médical
Année d’application
Thérapie
Pays
Âge du bénéficiaire
5401
Apheresis
Allogeneic
Chronic Myelomonocytic Leukemia
Hematology
2019
Standard Therapy
Poland
65
5402
Apheresis
Allogeneic
Chronic Myelomonocytic Leukemia
Hematology
2019
Standard Therapy
Poland
73
5403
Apheresis
Allogeneic
Chronic Myelomonocytic Leukemia
Hematology
2019
Standard Therapy
Poland
62
5404
Apheresis
Autologous
Diffuse Large B-Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
66
5405
Apheresis
Autologous
Embryonal Cell Carcinoma Of The Testicle
Hematology
2019
Standard Therapy
Germany
29
5406
Apheresis
Allogeneic
Extracranial Malignant Germ Cell Tumors
Hematology
2019
Standard Therapy
Poland
53
5407
Apheresis
Allogeneic
Glanzmann Thrombasthenia
Hematology
2019
Standard Therapy
Poland
11
5408
Apheresis
Allogeneic
High-Risk Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5409
Apheresis
Allogeneic
Histiocytosis X
Hematology
2019
Standard Therapy
Poland
14
5410
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
65
5411
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
58
5412
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
28
5413
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
44
5414
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
1
5415
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
32
5416
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2019
Standard Therapy
Poland
34
5417
Apheresis
Allogeneic
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Poland
62
5418
Apheresis
Allogeneic
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Poland
69
5419
Apheresis
Allogeneic
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Poland
65
5420
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
66
5421
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
63
5422
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
59
5423
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
68
5424
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
65
5425
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
54
5426
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
64
5427
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
59
5428
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
59
5429
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
71
5430
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2019
Standard Therapy
Germany
63
5431
Apheresis
Allogeneic
Mixed Phenotype Acute Leukemia
Hematology
2019
Standard Therapy
Poland
59
5432
Apheresis
Allogeneic
Mixed Phenotype Acute Leukemia
Hematology
2019
Standard Therapy
Poland
49
5433
Apheresis
Autologous
Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy
Hematology
2019
Standard Therapy
Germany
36
5434
Apheresis
Autologous
Morbus Hodgkin
Hematology
2019
Standard Therapy
Germany
66
5435
Apheresis
Allogeneic
Mucopolysaccharidosis Type I
Metabolic
2019
Standard Therapy
Poland
1
5436
Apheresis
Allogeneic
Mucopolysaccharidosis Type Ii
Metabolic
2019
Standard Therapy
Poland
2
5437
Apheresis
Allogeneic
Mucopolysaccharidosis Type Ii
Metabolic
2019
Standard Therapy
Poland
2
5438
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2019
Standard Therapy
Poland
52
5439
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2019
Standard Therapy
Poland
55
5440
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5441
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
58
5442
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
58
5443
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
69
5444
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
58
5445
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5446
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
52
5447
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
56
5448
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
54
5449
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
51
5450
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5451
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
52
5452
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
61
5453
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5454
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
59
5455
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5456
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
39
5457
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
52
5458
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
59
5459
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
63
5460
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
40
5461
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5462
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
53
5463
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5464
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
70
5465
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5466
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
56
5467
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
63
5468
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
35
5469
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
70
5470
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5471
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
41
5472
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
60
5473
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5474
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5475
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
63
5476
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5477
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
66
5478
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5479
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5480
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
67
5481
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5482
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
70
5483
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5484
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
66
5485
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5486
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
58
5487
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
59
5488
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
72
5489
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5490
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5491
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
55
5492
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5493
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
14
5494
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5495
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5496
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
75
5497
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
45
5498
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
70
5499
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
72
5500
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
69